You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BTAI Exercise Disclosure
Yocca Frank · SEC Form 4 · Filed Jun 17, 2026
Exercise
Calculated transaction value
$0
Yocca Frank Chief Scientific Officer
BTAI
BioXcel Therapeutics
BTAI
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
BTAI daily price context
Close on/before transaction
$1.16
Jun 15, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 35 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-075300
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bioxcel Therapeutics, Inc. BTAI | Exercise | Jun 15, 2026 | Not reported |
| Bioxcel Therapeutics, Inc. BTAI Current | Exercise | Jun 15, 2026 | $0 |